Adjuvant IFNα2 therapy of melanoma

被引：26

作者：

Kirkwood, JM ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 17213 USA

[2] Univ Pittsburgh, Inst Canc, Melanoma Ctr, Pittsburgh, PA 17213 USA

来源：

LANCET | 1998年 / 351卷 / 9120期

关键词：

D O I：

10.1016/S0140-6736(05)78608-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1901 / 1903

页数：3

共 11 条

[1]

Balch Charles M., 1997, P1947

[2] THICKNESS, CROSS-SECTIONAL AREAS AND DEPTH OF INVASION IN PROGNOSIS OF CUTANEOUS MELANOMA [J].

BRESLOW, A .

ANNALS OF SURGERY, 1970, 172 (05) :902-&

[3]

CASCINELLI N, 1995, P ASCO, V14, pA129

[4] Quality-of-life - adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group Study [J].

Cole, BF ;

Gelber, RD ;

Kirkwood, JM ;

Goldhirsch, A ;

Barylak, E ;

Borden, E .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2666-2673

[5] RANDOMIZED, SURGICAL ADJUVANT CLINICAL-TRIAL OF RECOMBINANT INTERFERON ALFA-2A IN SELECTED PATIENTS WITH MALIGNANT-MELANOMA [J].

CREAGAN, ET ;

DALTON, RJ ;

AHMANN, DL ;

JUNG, SH ;

MORTON, RF ;

LANGDON, RM ;

KUGLER, J ;

RODRIGUE, LJ .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) :2776-2783

[6] INTERFERON ALFA-2A THERAPY FOR LIFE-THREATENING HEMANGIOMAS OF INFANCY [J].

EZEKOWITZ, RAB ;

MULLIKEN, JB ;

FOLKMAN, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (22) :1456-1463

[7] Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from eastern cooperative oncology group 1684 [J].

Hillner, BE ;

Kirkwood, JM ;

Atkins, MB ;

Johnson, ER ;

Smith, TJ .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2351-2358

[8] Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684 [J].

Kirkwood, JM ;

Strawderman, MH ;

Ernstoff, MS ;

Smith, TJ ;

Borden, EC ;

Blum, RH .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :7-17

[9] PROLONGATION OF SURVIVAL IN METASTATIC MELANOMA AFTER ACTIVE SPECIFIC IMMUNOTHERAPY WITH A NEW POLYVALENT MELANOMA VACCINE [J].

MORTON, DL ;

FOSHAG, LJ ;

HOON, DSB ;

NIZZE, JA ;

WANEK, LA ;

CHANG, C ;

DAVTYAN, DG ;

GUPTA, RK ;

ELASHOFF, R ;

IRIE, RF .

ANNALS OF SURGERY, 1992, 216 (04) :463-482

[10] Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma [J].

Pehamberger, H ;

Soyer, HP ;

Steiner, A ;

Kofler, R ;

Binder, M ;

Mischer, P ;

Pachinger, W ;

Auböck, J ;

Fritsch, P ;

Kerl, H ;

Wolff, K .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1425-1429

← 1 2 →